Of all the cases of economic espionage charged by the DOJ's National Security Division since 2012, more than 80% of them implicated China.World Politicsread more
"Whilst there is a big dispute at the moment, I think there's also potential for resolution," UBS chairman Axel Weber says of the U.S.-China trade negotiations.World Economyread more
Cryptocurrency fans will hope the futures contracts, which are federally regulated, can provide some much-needed legitimacy to bitcoin.Cryptocurrencyread more
Despite mixed fan and critic reactions to the final season of "Game of Thrones," the eight-season epic took home the top prize in the drama category at the Emmy Awards on...Entertainmentread more
There are alternative financial centers and investors can turn to Singapore, Tokyo or Shanghai if Hong Kong doesn't "shape up," says the founder and chairman of Citic Capital.Asia Economyread more
The Kingdom and oil and gas industry have been slow to shore up defenses, raising red flags about the possibility of longer term fall-out in the region.Technologyread more
Tensions between South Korea and Japan may ultimately disrupt the high-end tech sectors, says Heenam Choi, CEO at South Korea's sovereign wealth fund.Traderead more
On Sunday, the 71st Primetime Emmy Awards honored the best comedies, dramas, limited and variety series from the last year.Entertainmentread more
U.S. President Donald Trump's national security advisor said on Sunday that White House Asia policy adviser Matt Pottinger would become his top deputy.Politicsread more
Removing Neumann is a difficult decision for Son, who has long believed in WeWork and Neumann's vision to quickly expand the company.Technologyread more
Datadog went public on Thursday and instantly hit a $10 billion valuation, becoming the fourth cloud software debut to reach that level this year.Technologyread more
Former FDA commissioner Robert Califf is in talks with Alphabet's life sciences arm Verily for a leadership role, according to several people familiar with the matter. (Update: Califf announced the news on Verily's blog on Wednesday.)
Califf has been spotted at the company's South San Francisco offices, said one person. The details of the position are still being worked out, and the talks could fall through, but Califf, a legendary cardiologist, is expected to take a joint role at Stanford and Verily.
Califf would join shortly after the launch of Verily's baseline study, a well-funded effort headed up by fellow cardiologist Jessica Mega to study human health by tracking 10,000 people over at least 4 years.
Both Stanford Medicine and Duke University, where Califf is currently on leave as a tenured cardiologist, have been named as partners in that study.
The appointment of Califf would be a big win for Verily, and couldn't come at a better time. The company just lost its top academic, former National Institute of Mental Health chief Tom Insel. Insel was the latest in a series of high-profile departures from Alphabet, Google's parent company, which also includes Nest's Tony Fadell, GV's Bill Maris, and Google Fiber chief Craig Barratt.
Califf was nominated for the FDA role by President Barack Obama and stepped down in January of this year, a standard procedure with a new administration. Shortly after stepping down, he spoke out in an interview about the antiquated ways in which companies collect medical data to test new drugs and medical devices. He suggested that clinical trials should look more like A/B comparison tests routinely done by tech companies, such as Google.
It's not typical for health agency chiefs to join technology companies, but it might increasingly be an option as Silicon Valley starts moving into regulated industries. Verily works closely with life sciences companies — including Dexcom,
Watch: Dr. Califf offers advice to his successor at FDA